We are live on ! Find out more
NEXI

NexImmune, Inc. Common Stock
NEXI

Delisted

NEXI was delisted on the 11th of July, 2024.

Back to rankings

32 hedge funds and large institutions have $1.26M invested in NexImmune, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

3% more funds holding

Funds holding: 31 → 32 (+1)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

43% less capital invested

Capital invested by funds: $2.2M → $1.26M (-$944K)

Holders
32
Holders Change
+1
Holders Change %
+3.23%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$15.5K
2
HF
HRT Financial
New York
+$14.5K
3
TSS
Two Sigma Securities
New York
+$8.18K
4
Renaissance Technologies
Renaissance Technologies
New York
+$5.93K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.8K

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$304K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$130K
3
Millennium Management
Millennium Management
New York
-$61K
4
BlackRock
BlackRock
New York
-$15K
5
SS
Simplicity Solutions
Minnesota
-$9.39K
Name Holding Trade Value Shares
Change 		Change in
Stake
SPC
1
Slate Path Capital
New York
$261K – – –
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$226K – – –
AO
3
Allen Operations
New York
$179K – – –
ECG
4
EPIQ Capital Group
California
$110K – – –
RJA
5
Raymond James & Associates
Florida
$90.4K – – –
PNC Financial Services Group
6
PNC Financial Services Group
Pennsylvania
$89.1K – – –
First Manhattan
7
First Manhattan
New York
$42K – – –
MCM
8
M28 Capital Management
Connecticut
$37.6K – – –
CG
9
Caprock Group
Idaho
$29.2K – – –
Vanguard Group
10
Vanguard Group
Pennsylvania
$27.4K -$130K -15,066 -79%
Envestnet Asset Management
11
Envestnet Asset Management
Illinois
$22.9K – – –
Geode Capital Management
12
Geode Capital Management
Massachusetts
$17.2K – – –
Millennium Management
13
Millennium Management
New York
$16.6K -$61K -7,077 -75%
Renaissance Technologies
14
Renaissance Technologies
New York
$16K +$5.93K +688 +44%
BCM
15
Bridgeway Capital Management
Texas
$13.9K – – –
Jane Street
16
Jane Street
New York
$12.7K +$15.5K +1,799 New
Bank of Montreal
17
Bank of Montreal
Ontario, Canada
$11.5K – – –
HF
18
HRT Financial
New York
$11K +$14.5K +1,678 New
DC
19
Davenport & Co
Virginia
$7.33K +$2.76K +320 +44%
TSS
20
Two Sigma Securities
New York
$6.69K +$8.18K +949 New
State Street
21
State Street
Massachusetts
$6.39K – – –
Two Sigma Investments
22
Two Sigma Investments
New York
$6.36K -$5.54K -643 -42%
Northern Trust
23
Northern Trust
Illinois
$3.57K – – –
BBA
24
Baader Bank Aktiengesellschaft
Germany
$3.44K -$4.75K -551 -46%
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$3.07K +$3.8K +441 New
1
2

NEXI Hedge Fund Activity: Q2 2023 in Review

32 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q2 2023, worth a combined $1.26M — down 43% from $2.2M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new NEXI positions and 4 closed out — a net gain of 1 holder — while 4 added to existing stakes and 6 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $15.5K. The largest seller was Citigroup, exiting entirely with an estimated $304K sold.

  • 32 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q2 2023, up from 31 in Q1 2023.
  • Funds reported $1.26M of NexImmune, Inc. Common Stock stock for Q2 2023, down 43% quarter-over-quarter.
  • 5 funds opened new NexImmune, Inc. Common Stock positions in Q2 2023 and 4 closed out, a net change of +1 holder.
  • The largest NexImmune, Inc. Common Stock buyer in Q2 2023 was Jane Street, an estimated $15.5K added.
  • The largest NexImmune, Inc. Common Stock seller in Q2 2023 was Citigroup, an estimated $304K sold.

Based on aggregated 13F filings for Q2 2023.